A look back at the week's news.
Teenaged girls at average risk don’t need Papanicolaou tests, but some special populations do.
Best practices on discussing birth control for adolescents.
If approved, ibrexafungerp would be the first and only approved therapy for both the treatment of vulvovaginal candidiasis (VVC) and the prevention of recurrent vulvovaginal candidiasis (RVVC).
Check out these latest resources from the American Urogynecologic Society.
Changes for ICD-10 documentation codes that go into effect in October 2022.
Tips to avoid wasting time and optimize meetings you do need.
Cesarean delivery reduces mortality risk in preterm breech births
December 2nd 2024In a recent study, infants born very preterm or extremely preterm had reduced odds of mortality when cesarean delivery was chosen as the mode of delivery, without a notable increase in any morbidity risk.
Read More
Emerging multiplex UTI testing drives Medicare costs amid increased utilization
November 27th 2024A recent study found a sharp rise in Medicare claims for multiplex urinary tract infection testing from 2016 to 2023, underscoring a significant financial impact and the need for further research into its clinical benefits.
Read More